GB2535427A — Solution
Assigned to Nicoventures Holdings Ltd · Expires 2016-08-24 · 10y expired
What this patent protects
A nicotine solution comprising a carrier; nicotine in unprotonated form and in protonated form; and one or more acids, wherein at least benzoic acid, levulinic acid or a mixture thereof is present; and wherein the total content of acid present in the solution is no greater than 0…
USPTO Abstract
A nicotine solution comprising a carrier; nicotine in unprotonated form and in protonated form; and one or more acids, wherein at least benzoic acid, levulinic acid or a mixture thereof is present; and wherein the total content of acid present in the solution is no greater than 0.6 mole equivalents based on the nicotine. Preferably the carrier is a solvent selected from glycerol, propylene glycol and mixtures thereof, and the composition further comprises water. Also claimed is the nicotine solution in a container, the nicotine solution as part of an electronic vapour provision system (e-cigarette). Vaporising a nicotine solution with benzoic acid and/or levulinic acid may improve the sensory properties of the overall solution.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.